Worldwide Clinical Trials

MAY 14, 2024

By: Amy Raymond, Derek Ansel, Nathan Chadwick, & Juliane Mills When choosing a CRO for a rare disease study, what truly sets them apart is their methodology: the CRO’s mindset, their approach to each unique study, and their agility in navigating the inherent complexities of rare disease research. Common goals empower change.

Trials 130

Trials Clinical Trials Clinical Trials Research 130

STAT News

NOVEMBER 1, 2022

The pandemic is a prime case study of what can be accomplished when science delivers. The pharmaceutical and biotech industry harnessed new technologies, collaborated in new ways, and worked at an accelerated pace to help prevent infections with SARS-CoV-2, the virus that causes Covid-19, and treat those who got the disease.

116

116

Rethinking Clinical Trials

FEBRUARY 14, 2024

It had a pragmatic recruitment model with an embedded design, multicenter study without local study investigators and management teams, and broad recruitment that included patients from all 50 states and Puerto Rico. The study randomized 13,523 patients across the U.S. from 72 VA healthcare systems.

Clinical Trials 154

Clinical Trials Clinical Trials Cardiology Trials 154

Medical Xpress

FEBRUARY 28, 2023

Pheochromocytoma is a rare tumor, with an incidence of three to eight cases per million population per year. The work published today, Feb 28, on Rare Disease Day 2023, in Nature Communications, is the largest study on this cancers' molecular causes and focuses on patients with metastatic pheochromocytomas, which account for 20% of all cases.

Research 75

Research 75

Pharmaceutical Technology

JUNE 19, 2023

IITK’s department of biological sciences and bioengineering (BSBE) has been working on gene therapy for a number of years and has developed assets as well as technology for new adeno-associated virus (AAV) vectors. The company stated that the collaboration with IIT Kanpur allows it to strengthen its presence in the CGT space.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

Pharmaceutical Technology

FEBRUARY 3, 2023

Once a patient is infected with HIV, they are infected for life, except for a few rare cases, he says. Additionally, advances in the study of broadly neutralising antibodies (bNAbs) have led to new candidates being studied in early trials. Mosaico was a collaboration between the NIAID, Janssen, USAMRDC, and others.

Vaccination 293

Vaccination Vaccine Antibody Trials 293

Drug Discovery World

DECEMBER 20, 2023

The post Case Study: How to generate publishable data in just 12 weeks appeared first on Drug Discovery World (DDW). How the researchers in Professor Srivastava’s lab have been able to generate publishable data on schizophrenia risk factors in just 12 weeks by optimising their students’ time at the bench. Download now.

Research 52

Research Drugs Development 52

Worldwide Clinical Trials

OCTOBER 26, 2022

Bringing a psychedelic into a clinical trial setting is complex and requires a thorough operational approach to ensure the study’s success. As we look to study psychedelic compounds in larger and more generalized populations, we need to execute these studies with rigor.

Trials 243

Trials Clinical Trials Clinical Trials Licensing 243

Pharmaceutical Technology

MAY 26, 2023

BSM project manager Lynne Anstett said: “It’s incredibly humbling to see how our team’s hard work is paying off and the impact it will have on people’s lives. Also included are reviews of key studies from scientific literature and a consideration of the interactions between cooling and warming rates, as applicable to cell and gene therapies.

Gene Therapy 264

Gene Therapy Gene FDA Approval Manufacturing 264

Pharmaceutical Technology

MAY 30, 2023

Amplo Biotechnology will work with UC-Davis CMS expert neurologist and researcher, Professor Ricardo Maselli, on the fast track STTR project. Also included are reviews of key studies from scientific literature and a consideration of the interactions between cooling and warming rates, as applicable to cell and gene therapies.

Gene Therapy 244

Gene Therapy Gene Development Clinical Trials 244

Rethinking Clinical Trials

MARCH 5, 2024

Firsthand experiences with embedded pragmatic clinical trials and case studies from the NIH Pragmatic Trials Collaboratory will support and illustrate the topics presented. Small group hands-on learning activity in which attendees work together to problem-solve real challenges encountered in embedded pragmatic clinical trials.

Trials 154

Trials Clinical Trials Clinical Trials Clinical Research 154

World of DTC Marketing

MARCH 1, 2021

Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. That’s why every company needs to work hard to earn trust from their customers everyday. . The fact that 40% of Type 2 diabetes cases are caused by obesity is alarming and costs us.

Vaccination 180

Vaccination Vaccine Pharma Companies Drugs 180

World of DTC Marketing

FEBRUARY 8, 2022

Now that big companies prioritize employees’ mental health, some apps work with them to help entire workforces. Threatening to share details of extramarital affairs and, in some cases, thoughts about pedophilia, the hackers reportedly demanded bitcoin ransoms from some 30,000 patients on the dark web.

Marketing 241

Marketing Doctors Doctor Development 241

Drug Discovery World

DECEMBER 20, 2023

In this Case Study you will learn: How Professor Deepak Srivastava’s lab at King’s College London are working to unpick the complex bio logy of neuronal synapses to help us better understand neurological disorders like schizophrenia.

Research 52

Research Drugs Development 52

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”

Development 147

Development Drugs Medicine Research 147

Scienmag

FEBRUARY 20, 2022

Using Colombia as a case study, this work presents one of the most comprehensive studies to date comparing forest loss to drivers such as coca cultivation and cattle farming during periods of peace […].

66

66

Deltaclinical

JUNE 5, 2023

Traditionally, these studies were conducted in medical facilities, but today clinical studies with home visits are becoming increasingly popular. Instead of having to travel repeatedly to a medical facility, patients can stay in their own familiar surroundings while study procedures can simply be done at their home.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Deltaclinical

JUNE 5, 2023

Traditionally, these studies were conducted in medical facilities, but today clinical studies with home visits are becoming increasingly popular. Instead of having to travel repeatedly to a medical facility, patients can stay in their own familiar surroundings while study procedures can simply be done at their home.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Pharmaceutical Technology

MAY 4, 2023

Also included are reviews of key studies from scientific literature and a consideration of the interactions between cooling and warming rates, as applicable to cell and gene therapies. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

Rethinking Clinical Trials

OCTOBER 11, 2023

Moyer, PhD Statistician, NIH Office of Disease Prevention Slides Keywords Implementation; Study design; Hybrid; Clustered; DECIPHeR Key Points People often contest that hybrid designs are not as rigorous as they should be. In implementation studies, how can you blind outcome assessor? Learn more Visit the DECIPHeR website.

Clinical Trials 154

Clinical Trials Clinical Trials Trials Research 154

Pharmaceutical Technology

MAY 2, 2023

Marker Therapeutics CEO Juan Vera stated: “Marker’s management and impartial members of the board worked with John Wilson and CellReady to develop a very creative and non-dilutive plan that provides Marker with the financial runway to pursue its clinical priorities through the end of 2025. “At

Manufacturing 130

Manufacturing Gene Therapy Gene Development 130

Worldwide Clinical Trials

JUNE 15, 2022

In case you missed it, you can watch the full webinar, here , or check out the top five things you missed: 1. can help you prepare your study and documentation to comply with agencies. To discuss your study and how to reduce the chances of receiving a clinical hold, talk with us. . Sites are struggling to activate — even now. .

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

pharmaphorum

AUGUST 24, 2021

Joint working could hold at least part of the answer to getting the NHS back on its feet after COVID, according to the ABPI. Our member companies have been working on collaborative projects with the NHS for at least a decade now,” she said. “At NHS-pharma joint working case studies. Tackling NHS COVID challenges.

Compliance 59

Compliance Medicine Containment Marketing 59

Drug Discovery World

MARCH 10, 2023

In China, there were nearly 86,000 new cases of bladder cancer in 2020, and we are working with the NMPA to seek approval for enfortumab vedotin for patients with advanced stage disease,” said Ahsan Arozullah, Senior Vice President and Head of Development Therapeutic Areas, Astellas. 100,000 cases, or 235,393 cases.

Drugs 52

Drugs Licensing Licensing Production 52

XTalks

AUGUST 20, 2020

As part of efforts to find solutions for the current coronavirus pandemic, Fitbit has released data from a collaborative study it has undertaken with researchers at Stanford University and The Scripps Research Institute on the use of wearable health trackers for the detection of COVID-19. Symptoms and Predictors.

Medicine 98

Medicine Research Development Genome 98

World of DTC Marketing

FEBRUARY 2, 2022

While some doctors have been eager to start prescribing the newly approved drug, others had criticized the FDA for clearing the drug before studies proved it works. Top researchers who advised the U.S. Biogen claims the benefits of slowing declines in cognition and day-to-day function are worth this price.

FDA Approval 239

FDA Approval Drugs Doctors Doctor 239

Camargo

SEPTEMBER 30, 2021

The drug development process is a long journey, beginning with drug discovery, moving through nonclinical and clinical studies, and ultimately culminating in regulatory approval. Nonclinical studies are not a mere tick-box exercise in a drug development program. GLP-Compliant vs Non-GLP Studies. Nonclinical Considerations.

Development 201

Development Research Manufacturing In-Vivo 201

Pharmaceutical Technology

NOVEMBER 24, 2022

This shift will be driven by the future of work and digital transformation initiatives ongoing across sectors ranging from retail to healthcare and financial services. Big Tech is championing the metaverse, with Microsoft and Meta promoting it as the ideal environment to support hybrid working. The future of work.

Branding 130

Branding Development Marketing Regulation 130

Camargo

NOVEMBER 22, 2021

It also helps raise awareness of the often-overwhelming issues they face, so that we can work together as a society to alleviate them. But our original doctor doesn’t work with clinical trials—it’s just not his thing. Can he work? Should he work? In some cases, I do. What do we tell the kids?

Clinical Trials 198

Clinical Trials Clinical Trials Trials Life Science 198

XTalks

APRIL 21, 2023

By using novel artificial intelligence (AI) tools for drug safety and real-world evidence (RWE) studies, the two companies will help the FDA improve the understanding of the effects of medicines on real-world populations. The remaining cases indicated that other additional risk factors might have contributed to suicide.

Life Science 98

Life Science Allergies Drugs FDA Approval 98

Pharma Marketing Network

JULY 25, 2023

Look for agencies that specialize in your industry or have experience working with businesses similar to yours. Evaluate how long the agency has been in business and the clients they have worked with. Request case studies or references to gain insights into their past projects and success stories.

Marketing 98

Marketing Engineer Branding Research 98

FDA Law Blog

NOVEMBER 13, 2023

Designed for in-house legal and compliance counsel, industry executives, and private practice attorneys working for the OTC drug industry, the event will welcome distinguished industry thought leaders – including from the National Advertising Division and FDA – to share their expertise and strategic insights. Director Deborah L.

Compliance 59

Compliance Drugs Cosmetics 59

Clinical Trial Podcast

APRIL 23, 2023

In this episode, we’re going to talk about Postmarket Surveillance Studies. In light of the EU Medical Device Regulation (MDR), medical device manufacturers are required to implement a Postmarket Surveillance (PMS) plan, which in turn may require them to conduct Postmarket Surveillance Studies.

Clinical Trials 52

Clinical Trials Clinical Trials Regulation Production 52

pharmaphorum

FEBRUARY 22, 2022

A study has revealed that current NHS guidelines on testing for genetic alterations linked to cancer could be missing around half of people carrying them, says a new study. There is a trade-off to doing so, however, through an increased chance of ambiguous findings which need follow-up and can worry patients unnecessarily, she added.

Gene 105

Gene Genetics Scientist Research 105

Cloudbyz

MARCH 3, 2023

It involves the CRA visiting the study site to ensure that the site is prepared to conduct the study according to the protocol and Good Clinical Practice (GCP) guidelines. Confirm that the site has all the necessary study documents, including the protocol, informed consent form, case report form, and monitoring plan.

Clinical Trials 71

Clinical Trials Clinical Trials Trials Clinical Research 71

pharmaphorum

SEPTEMBER 15, 2021

Researchers in the UK are working on an artificial intelligence (AI) algorithm to help diagnose deep vein thrombosis (DVT) from ultrasound images – and potentially prevent patients from receiving drugs unnecessarily. This is the first study to show that machine learning algorithms can potentially diagnose DVT, according to the researchers.

Scientist 108

Scientist Research Medicine Drugs 108

pharmaphorum

MAY 30, 2022

pharmaphorum sat down with Sunil Verma, global head of oncology, medical, at AstraZeneca, to discuss three studies that were presented at the show, which demonstrate a few of the ways oncology is advancing through precision medicine and targeted therapies. The Daisy Study – ADCs in HER2-expressive patients. The Trojan horse.

Antibody 115

Antibody Drugs Medicine Research 115